← Back to headlines
Resmed and Under Armour Cut FY27 Outlook Amid Soft Demand
Resmed's stock fell by 7% and Under Armour cut its fiscal year 2027 sales outlook, both citing soft demand as a primary factor.
10 Aug, 11:08 — 10 Aug, 11:08
Sources
Showing 1 of 1 sources
